Mach7 Technologies Limited (TDMMF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in AUD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | AUD m | 19 | 19 | 26 | 30 | 17 | 34 | 28 | 29 |
| Operating profit | AUD m | 1 | -8 | ||||||
| Net profit | AUD m | 0 | -9 | -4 | -1 | -8 | -6 | -9 | -8 |
| EPS reported | AUD | -0.03 | -0.04 | ||||||
| Operating cashflow per share | AUD | 0.00 | -0.00 | ||||||
| Capex per share | AUD | 0.00 | 0.00 | ||||||
| FCF per share | AUD | 0.00 | -0.00 | ||||||
| Free cash flow | AUD m | 0 | -1 | ||||||
| Net debt | AUD m | -23 | -20 | ||||||
| Book value equity | AUD m | 46 | 35 | ||||||
| Book value per share | AUD | 0.19 | 0.15 | ||||||
| Number of shares | m | 240.12 | 235.01 | ||||||
| DPS (TTM paid) | AUD | 0.00 | 0.00 |
Financial summary
Financials in AUD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.92 | 2.54 | ||||||
| P/S LTM | x | 2.59 | 3.14 | ||||||
| P/FCF LTM | x | 775.43 | -65.59 | ||||||
| EV/EBITDA LTM | x | -9.29 | -55.65 | ||||||
| EV/Sales LTM | x | 1.94 | 1.85 | ||||||
| Earnings Yield LTM | % | -7.08% | -14.07% | ||||||
| FCF Yield | % | +0.13% | -1.52% | ||||||
| Quality | |||||||||
| ROE | % | -13.61% | -23.86% | ||||||
| ROIC | % | +1.23% | -25.36% | ||||||
| Operating margin | % | +1.81% | -36.18% | ||||||
| Gross margin | % | +24.81% | +5.17% | ||||||
| FCF/Sales | % | +0.33% | -1.94% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +95.93% | +61.70% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -96.58% | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.10 | -16.63 | ||||||
| Net Debt/EBITDA | x | 3.11 | 2.58 | ||||||
| EBIT/Net interest | x | 7.90 | -97.09 | ||||||
| Net debt/market cap | % | 0.00% | +1.38% | ||||||
| Net debt/Equity | x | -0.51 | -0.57 | ||||||
| Gross debt/equity | x | 0.02 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free